Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

Fatty liver disease, also known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a chronic liver ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Fact checked by Nick Blackmer I was first told that I was at higher risk for fatty liver disease in 2005. I had never heard ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...